is there a peptide that helps with vitiligo FAQ

The most common side effects are infections in the nose or throat, a sore throat, or common cold symptoms. These can also include serious infections. The best way to prevent infections is to reduce your exposure to germs by washing your hands and avoiding people who are sick. You should stay current on vaccinations, such as getting an annual flu vaccine. Call your health care provider if you have these symptoms of infection:

Several medicines can affect the blood levels of Opzelura. This may increase the risk of side effects. The following medicines should be avoided. Talk with your health care provider if you are using any of the following medicines or foods:

Two studies were done to see if Opzelura was safe and effective for the treatment of vitiligo, compared with a placebo. Placebo-controlled studies help researchers see differences in benefit or harm of a medicine when compared with no treatment. People in both studies had small areas of non-segmental vitiligo, including the face and other areas of the body. The severity of the vitiligo on the total body and face was measured by the Vitiligo Area Scoring Index (VASI, see table below).

Vitiligo is a long-term (chronic) condition where you lose color (pigment) in your skin. This is due to an overactive immune system. The immune system attacks your skin color cells (melanocytes), making your skin look white or pink in patchy areas. Some people have more patches of color loss or will have color loss on specific sides of the body. This can happen anywhere on the body and can cause:

If Opzelura is working, you should start to see repigmentation after two to three months of regular use. It could take up to six months to see meaningful changes in skin color. In some areas of the body, like the face, you may see faster changes. People sometimes notice tiny spots of pigment in the white patches (perifollicular repigmentation). It is a slow process, and continued treatment is needed to see more results. Contact your health care provider if you don’t see improvements after three months or continue to have symptoms that bother you. Do not stop using Opzelura without talking with your health care provider. If you stop Opzelura, you may see more skin color loss.

Opzelura should not be used when you have an active infection. Talk to your health care provider about any of the following:

Opzelura is a cream that is applied as a thin layer, twice a day, on the areas of skin color loss. Talk with your pharmacist or other health care provider if you have questions about how and where to use Opzelura. It is important to wash your hands after applying the cream, unless you are putting on a spot on your hands. Do not cover the affected area with a bandage or other wrap, unless your health care provider tells you to. If you are using other topical medicines or moisturizers, talk to your health care provider about what to continue and how to use them along with Opzelura.

After 24 weeks of treatment, people using Opzelura were more likely to have decreases in VASI scores, meaning more visible repigmentation in the face and total body areas.